Intraoperative Use of Oxygen Saturation Imaging to Assess Intestinal Perfusion
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of Southern California
- Study ID
- NCT07587619
- Phase
- PHASE1/PHASE2
- Status
- Active Not Recruiting
Conditions
- Colorectal Cancer
- Diverticulitis of Sigmoid
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Fujifilm monitoring — DEVICEMonitoring with Fujifilm ELUXEO device endoscopically \& laparoscopically
Study Details
This will be a prospective, observational study of patients undergoing laparoscopic colorectal resection with anastomosis. After anastomosis creation and at the time of routine intraoperative flexible sigmoidoscopy, 4 mucosal StO2 measurements will be taken endoscopically and 4 corresponding serosal StO2 measurements will be taken laparoscopically. Measurements will be recorded in a prospectively maintained database along with operative findings and clinical outcomes. Longitudinal data will be obtained via chart review to track longer-term outcomes.
Key Dates
- Start date
- Sep 3, 2024
- Status verified
- Mar 2026
- Primary completion
- Sep 17, 2025
- Completion
- Jul 1, 2026
Study Design
- Enrollment
- 52 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Fujifilm monitoringFujifilm monitoring
Primary Outcome Measure
Anastomotic leak [ Time Frame: 30 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 90033 | - |
Find similar trials in Los Angeles, CA
By condition
By specialty
By research site
Related Studies
- ColoCare Study - Colorectal Cancer CohortRecruiting · University of Utah · Los Angeles, California
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPHASE1/PHASE2 · Recruiting · IDEAYA Biosciences · Los Angeles, California
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesPHASE1 · Recruiting · BioEclipse Therapeutics · Scottsdale, Arizona